Legend Biotech CEO files initial ownership report

Legend Biotech Corp (LEGN) reported that Ingrid Zhang, Chief Executive Officer, has filed an initial statement of beneficial ownership as an officer of the company.

Rhea-AI Filing Summary

Legend Biotech Corp (LEGN) reported that Ingrid Zhang, Chief Executive Officer, has filed an initial statement of beneficial ownership as an officer of the company. The report lists no equity transactions or holdings and notes an attached Exhibit 24 – Power of Attorney.

Key Figures

Reported buy transactions: 0 transactions Reported sell transactions: 0 transactions Holding entries reported: 0 holdings

3 metrics

Reported buy transactions 0 transactions Initial statement of beneficial ownership for Ingrid Zhang

Reported sell transactions 0 transactions Initial statement of beneficial ownership for Ingrid Zhang

Holding entries reported 0 holdings Summary holding entries in the Form 3 data

Key Terms

Power of Attorney, beneficial ownership, Form 3

3 terms

Power of Attorney regulatory

"Remarks note “Exhibit 24 - Power of Attorney” for the reporting person"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

beneficial ownership financial

"Initial statement of beneficial ownership filed for the Chief Executive Officer"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Form 3 regulatory

"Initial Form 3 statement filed for Ingrid Zhang at Legend Biotech"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Legend Biotech (LEGN) disclose about Ingrid Zhang in this Form 3?

The Form 3 identifies Ingrid Zhang as Chief Executive Officer of Legend Biotech Corp and serves as her initial statement of beneficial ownership, with no equity transactions or holdings reported.

Are any share purchases or sales reported for Ingrid Zhang in LEGN’s Form 3?

No. The Form 3 shows no reported purchases or sales of Legend Biotech Corp securities by Ingrid Zhang, and the transaction counts and share amounts are all zero.

Does the LEGN Form 3 for Ingrid Zhang report any current holdings?

No. The summary data indicates 0 holding entries

Is there any Rule 10b5-1 trading plan indicated in Ingrid Zhang’s LEGN Form 3?

No Rule 10b5-1 trading plan is indicated. The plan status field is null, and there are no footnotes or transaction details referencing a trading plan.

What is the significance of Exhibit 24 mentioned in Legend Biotech’s Form 3?

The remarks reference “Exhibit 24 - Power of Attorney”, indicating that a power of attorney has been filed, authorizing designated persons to sign or submit documents on behalf of Ingrid Zhang.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:16 PM Accepted by SEC EDGAR 09/16/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Zhang Ingrid

(Last) (First) (Middle)

C/O LEGEND BIOTECH CORP

77 CORPORATE DRIVE, 4TH FLOOR

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/15/2026

3. Issuer Name and Ticker or Trading Symbol
Legend Biotech Corp [ LEGN ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Robert Staloff, Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)